Psychiatric Treatment and Care

Clinical Neuroscience

• From Psychiatry to Clinical Neuroscience: Four Inconvenient Truths
• Psychiatry and Developmental Neuroscience: Guiding Principles From Research on Anxiety
• Updates in Neuropsychiatry: Chronic Fatigue Syndrome – What Electrophysiology and Neuroimaging Can Tell Us About Its Pathophysiology
• Psychiatry, Neuroscience and Behavioral Health Care: Essential Investments in the Emerging American Health Care Marketplace

Integrative Medicine

• Introduction to Complementary, Alternative, and Integrative Medicine in Psychiatry
• Mind Body Medicine: The Link Between Clinical Medicine and Public Health

Psychotherapy

• Cognitive Therapy and Psychodynamic Psychotherapy
• Evidence-Based Psychotherapies for Borderline Personality Disorder
• Moving from Treatment as Usual to Good Clinical Care of Personality Disorder Traits
• Positive Psychiatry and Resilience

Psychopharmacology

• Advances in Managing the Side Effects of Psychotropic Medications
• Methadone and Buprenorphine: Clinical Impact of Drug Interactions
• Using Clozapine: Public and Academic Approaches to Full Recovery

Psychiatric Disorders

• Advances in Treatments of Psychiatric Disorders
• The Classification of Personality Disorders – New Developments
• Challenging Treatment Issues in Schizophrenia
• Redefining the Distinctions Between Borderline Moods and Mood Disorders

Substance Related and Addictive Disorders

• Advances in Addiction Psychopharmacology
• DSM-5: Substance Related and Addictive Disorders
• Choosing the Right Treatments for Substance Use Disorder

Alcohol, Tobacco, Marijuana

• Assessing the Efficacy of Varenicline Tartrate for Alcohol Dependence
• Myths and Misperceptions of Opioids and Cannabis
• The Psychology of AA and NA and Their Role in Clinical Care
• Update on Treatment of Tobacco Use Disorder

Medication-Assisted Treatment

• A Group-Based Approach to Medication Assisted Treatment For Opioid Use Disorders
• Managing Acute and Chronic Pain in Patients on Medication Assisted Treatment

Opioid Therapies

• A Review of and Perspectives on Buprenorphine Diversion and Misuse
• Addressing Opioid Misuse and Abuse: ONDCP and SAMHSA Partnership to Reduce Risk
• Opioid Agonist Therapy - To Maintain or Not to Maintain (case discussion)
• Opioid Agonist Therapy: The Duration Dilemma
• Surprising Perspectives on Treating Co-occurring Depression and Opioid Use Disorder
• Treating Co-Occurring Depression and Opioid Use Disorder (case discussion)
• Treatment Options for Opioid Dependence: A Role for Agonists vs. Antagonists

Pain Management

• Treatment of Comorbid Opioid Addiction and Chronic Pain
• Managing Acute and Chronic Pain - A Case Discussion
• Managing Buprenorphine in Patients with Co-Occurring Pain and Addiction
• Managing Pain in Patients with an Addiction History
• National Institutes of Health Pain Consortium Efforts to Enhance Pain Treatment
• Opioid Therapy, Pain, and Addiction at the Crossroads
• Prescription Pain Medication and Heroin: A Changing Picture

Special Settings

• Assessment and Management of Opioid Use Disorders in the General Hospital Setting
• Clinical Case Reviews: Managing Diversion and Misuse in Office-Based Opioid Treatment (OBOT)
• Integration and Sustainability of Office-Based Opioid Treatment in Federally Qualified Health Centers With Nurse Care Managers
• Clinical Case Discussion on the Assessment and Management of Opioid Use Disorders in the General Hospital Setting

Suicide

• Frontiers in Suicide Risk Assessment
• Minimizing Risk When Treating Suicidal and Violent Patients